Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
52,122,667
-
Total 13F shares
-
28,210,083
-
Share change
-
+16,466,303
-
Total reported value
-
$84,630,390
-
Price per share
-
$3.00
-
Number of holders
-
28
-
Value change
-
+$49,505,803
-
Number of buys
-
13
-
Number of sells
-
16
Institutional Holders of Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP) as of Q3 2025
As of 30 Sep 2025 Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP) had 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 28,210,083 shares of stock of the company.
Largest 10 holders included 5AM Venture Management, LLC, JANUS HENDERSON GROUP PLC, Vivo Capital, LLC, ENAVATE SCIENCES GP, LLC, FMR LLC, a16z Capital Management, L.L.C., ADAGE CAPITAL PARTNERS GP, L.L.C., HarbourVest Partners LLC, SILVERARC CAPITAL MANAGEMENT, LLC, and VANGUARD GROUP INC.
This table shows 28 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.